Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems and Promega Settle Litigation Over PCR Technology

NEW YORK, Sept. 26 (GenomeWeb News) - Applied Biosystems has settled its litigation with Promega over PCR technology, the company said today.

 

Promega originally sued Hoffman-La Roche and Applera in the US District Court for the Eastern District of Virginia on behalf of the USgovernment but the court dismissed the company's amended complaint with prejudice a year ago. Both Promega and Applera filed appeals at the time, which they have now withdrawn.

 

Promega's suit was based on the False Claims Act, also known as the Informer's Act or the Qui Tam Statute, which allows a private person to sue a person or company that knowingly submits false bills to the federal government.

 

Following the settlement, Promega can now negotiate a license to Roche's PCR patents with ABI, the exclusive licensor of the patents for life science research and applied fields, according to ABI.

 

Earlier in the month, Promega settled its PCR-related litigation with Roche.